Services, and other Federal entities charged with the re-
sponsibility for the delivery of health care services or re-
search on pain, with respect to pain management.
(f) CONSULTATION.—In carrying out this section, the
Advisory Committee shall consult with all Federal agen-
cies that are responsible for providing health care services
or access to health services to determine the best means
to ensure that all Federal activities are coordinated with
respect to research and access to pain and symptom man-
agement.
(g) ADMINISTRATIVE SUPPORT; TERMS OF SERVICE;
OTHER PROVISIONS.—The following shall apply with re-
spect to the Advisory Committee:
(1) The Committee shall receive necessary and
appropriate administrative support, including appro-
priate funding, from the Department of Health and
Human Services.
(2) The Committee shall hold open meetings
and meet not less than 4 times per year.
(3) Members of the Committee shall not receive
additional compensation for their service. Such
members may receive reimbursement for appropriate
and additional expenses that are incurred through
service on the Committee which would not have in-
curred had they not been a member of the Com-
mittee.
(4) The requirements of appendix 2 of title 5,
United States Code.
SEC. 402. INSTITUTES OF MEDICINE REPORT ON CON-
TROLLED SUBSTANCE REGULATION AND THE
USE OF PAIN MEDICATIONS.
(a) IN GENERAL.—The Secretary, acting through a
contract entered into with the Institute of Medicine, shall
review findings that have been developed through research
conducted concerning—
(1) the effects of controlled substance regula-
tion on patient access to effective care;
(2) factors, if any, that may contribute to the
underuse of pain medications, including opioids; and
(3) the identification of State legal and regu-
latory barriers, if any, that may impact patient ac-
cess to medications used for pain and symptom man-
agement.
(b) REPORT.—Not later than 18 months after the
date of enactment of this Act, the Secretary shall prepare
and submit to the appropriate committees of Congress a
report concerning the findings described in subsection (a).
SEC. 403. CONFERENCE ON PAIN RESEARCH AND CARE.
Not later than December 31, 2003, the Secretary,
acting through the National Institutes of Health, shall
convene a national conference to discuss the translation
of pain research into the delivery of health services to
chronic pain patients and those needing end-of-life care.
The Secretary shall use unobligated amounts appropriated
for the Department of Health and Human Services to
carry out this section.
TITLE V—DEMONSTRATION
PROJECTS
SEC. 501. PROVIDER PERFORMANCE STANDARDS FOR IM-
PROVEMENT IN PAIN AND SYMPTOM MAN-
AGEMENT.
(a) IN GENERAL.—The Secretary, acting through the
Public Health Service, shall award grants for the estab-
lishment of not less than 5 demonstration projects to de-
termine effective methods to measure improvement in the
skills and knowledge of health care personnel in pain and
symptom management as such skill and knowledge applies
to providing services to chronic pain patients and those
patients requiring pain and symptom management at the
end of life.
(b) EVALUATION.—Projects established under sub-
section (a) shall be evaluated to determine patient and
caregiver knowledge and attitudes toward pain and symp-
tom management.
(c) APPLICATION.—To be eligible to receive a grant
under subsection (a), an entity shall prepare and submit
to the Secretary an application at such time, in such man-
ner and containing such information as the Secretary may
require.
(d) TERMINATION.—A project established under sub-
section (a) shall terminate after the expiration of the 2-
year period beginning on the date on which such project
was established.
(d) AUTHORIZATION OF APPROPRIATIONS.—There is
authorized to be appropriated such sums as may be nec-
essary to carry out this section.
Æ